Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease
Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease
Background: Health-related quality of life (HRQOL) questionnaires currently being used to evaluate allergic disease are organ-specific. They therefore fail to take account of the systemic aspects of allergic disease. Objective: To develop and validate a pediatric HRQOL questionnaire for allergic disease (Pediatric Allergic Disease Quality of Life Questionnaire, PADQLQ) that encapsulates problems related to the eyes, ears, nose, lungs, skin, emotions, and everyday activities. Methods: In the development phase, 77 subjects (6 to 16 years of age), with seasonal or perennial allergic problems, were asked how much they were bothered by each different area of HRQOL impairment. The highest scoring areas were used to construct the PADQLQ. In the validation phase of the study, 36 subjects (8 to 16 years of age) with seasonal allergic rhinoconjunctivitis, seasonal allergic asthma, and/or cutaneous manifestations of grass pollen allergy were assessed before and during the pollen season. Results: The PADQLQ contains 26 questions. In addition to standard symptoms (eg, rhinitis), it incorporates multiorgan symptoms that are usually overlooked (eg, hearing problems). The PADQLQ demonstrated good cross-sectional and longitudinal validity, showing a high degree of correlation with symptom scores and quality of life as measured by a visual analogue scale and two-organ specific questionnaires. The PADQLQ showed good within-subject reliability and a small minimal important difference (0.33; 95% CI, 0.11 to 0.54 on a 7-point scale). Conclusions: The PADQLQ has good cross-sectional and longitudinal validity, making it a potentially useful outcome measure in the evaluation of systemic treatments such as antihistamine medications and immunotherapy in children with multisystem allergic disease.
quality of life, multisystem allergic disease, asthma, rhinoconjunctivitis, eczema, children, teenagers
491-497
Roberts, Graham
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Hurley, Catriona
7ed3fff1-7a17-4763-a70f-4b7180b2bc7d
Lack, Gideon
cac030a2-c358-4880-a91d-d67d06e8e321
March 2003
Roberts, Graham
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Hurley, Catriona
7ed3fff1-7a17-4763-a70f-4b7180b2bc7d
Lack, Gideon
cac030a2-c358-4880-a91d-d67d06e8e321
Roberts, Graham, Hurley, Catriona and Lack, Gideon
(2003)
Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease.
Journal of Allergy and Clinical Immunology, 111 (3), .
(doi:10.1067/mai.2003.138).
Abstract
Background: Health-related quality of life (HRQOL) questionnaires currently being used to evaluate allergic disease are organ-specific. They therefore fail to take account of the systemic aspects of allergic disease. Objective: To develop and validate a pediatric HRQOL questionnaire for allergic disease (Pediatric Allergic Disease Quality of Life Questionnaire, PADQLQ) that encapsulates problems related to the eyes, ears, nose, lungs, skin, emotions, and everyday activities. Methods: In the development phase, 77 subjects (6 to 16 years of age), with seasonal or perennial allergic problems, were asked how much they were bothered by each different area of HRQOL impairment. The highest scoring areas were used to construct the PADQLQ. In the validation phase of the study, 36 subjects (8 to 16 years of age) with seasonal allergic rhinoconjunctivitis, seasonal allergic asthma, and/or cutaneous manifestations of grass pollen allergy were assessed before and during the pollen season. Results: The PADQLQ contains 26 questions. In addition to standard symptoms (eg, rhinitis), it incorporates multiorgan symptoms that are usually overlooked (eg, hearing problems). The PADQLQ demonstrated good cross-sectional and longitudinal validity, showing a high degree of correlation with symptom scores and quality of life as measured by a visual analogue scale and two-organ specific questionnaires. The PADQLQ showed good within-subject reliability and a small minimal important difference (0.33; 95% CI, 0.11 to 0.54 on a 7-point scale). Conclusions: The PADQLQ has good cross-sectional and longitudinal validity, making it a potentially useful outcome measure in the evaluation of systemic treatments such as antihistamine medications and immunotherapy in children with multisystem allergic disease.
This record has no associated files available for download.
More information
Submitted date: 20 June 2002
Published date: March 2003
Keywords:
quality of life, multisystem allergic disease, asthma, rhinoconjunctivitis, eczema, children, teenagers
Identifiers
Local EPrints ID: 27376
URI: http://eprints.soton.ac.uk/id/eprint/27376
ISSN: 0091-6749
PURE UUID: 3f445bae-bf82-47f8-ac37-3f4abe0a43b6
Catalogue record
Date deposited: 27 Apr 2006
Last modified: 16 Mar 2024 03:44
Export record
Altmetrics
Contributors
Author:
Catriona Hurley
Author:
Gideon Lack
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics